Article Details

AstraZeneca's Ondexxya gets approval in Japan to reverse effect of anti blood clot drugs

Retrieved on: 2022-03-29 09:19:33

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's Ondexxya gets approval in Japan to reverse effect of anti blood clot drugs. View article details on hiswai:

Excerpt

The Japanese Ministry of Health, Labour and Welfare approved AstraZeneca's (AZN) Ondexxya for patients treated with the Factor Xa (FXa) inhibitors ...

Article found on: seekingalpha.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up